Holen Sie sich die Stockscreener-App
47.17
0.84%
-0.40
Handel nachbörslich:
47.78
0.61
+1.29%
Guardant Health Inc Aktie (GH) Neueste Nachrichten
Guardant Health (NASDAQ:GH) Sets New 12-Month HighWhat's Next? - MarketBeat
Guardant Health (NASDAQ:GH) Trading Down 5.7%Should You Sell? - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Shares Sold by SG Americas Securities LLC - MarketBeat
Why Guardant Health, Inc. (GH) Is Among the Best Booming Stocks to Invest in Now? - Insider Monkey
Exchange Traded Concepts LLC Decreases Stock Position in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
12 Best Booming Stocks to Invest in Now - Insider Monkey
The Goldman Sachs Group Raises Guardant Health (NASDAQ:GH) Price Target to $49.00 - MarketBeat
Guardant Health (NASDAQ:GH) Given New $49.00 Price Target at The Goldman Sachs Group - MarketBeat
Abu Dhabi selects Guardant Health’s Shield Test for blood-based colorectal cancer screening programme - BSA bureau
Guardant Health stock soars to 52-week high of $49.97 - MSN
Guardant Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025 - Milton Daily Standard
Guardant Health stock soars to 52-week high of $49.97 By Investing.com - Investing.com Nigeria
Guardant Health Selected by Abu Dhabi Health Department to Launch Colorectal Cancer Screening Program - Marketscreener.com
Guardant Health Secures Landmark Deal: 10,000 Cancer Screenings Set for Abu Dhabi - StockTitan
Okla And Rigetti Computing Are Among Top 8 Mid Cap Gainers Last Week (Jan 20-Jan 24): Are The Others In Your Portfolio? - Benzinga
Why Guardant Health (GH) Is Skyrocketing Now - Insider Monkey
Guardant Health (NASDAQ:GH) Stock Price Up 6.4%What's Next? - MarketBeat
Guardant Health stock target raised to $55 by BTIG - MSN
Barclays Initiates Coverage of Guardant Health (GH) with Overweight Recommendation - MSN
Leerink Partnrs Weighs in on Guardant Health Q4 Earnings - Defense World
Barclays initiates Guardant Health stock with Overweight rating By Investing.com - Investing.com Canada
Guardant Reveal aids organ preservation in rectal cancer treatment - Investing.com India
Barclays Begins Coverage on Guardant Health (NASDAQ:GH) - MarketBeat
Barclays initiates Guardant Health stock with Overweight rating - Investing.com
Q4 EPS Estimate for Guardant Health Increased by Analyst - MarketBeat
Guardant Health to Present Major Cancer Detection Breakthroughs at ASCO GI 2025 Symposium - StockTitan
Why Guardant Health, Inc. (GH) Soared At The Start Of The Trading Week - MSN
Guardant Health (NASDAQ:GH) Shares Up 6.4%Here's Why - MarketBeat
Guardant Health's (GH) "Buy" Rating Reaffirmed at Guggenheim - MarketBeat
Guardant Health stock hits 52-week high of $39.61 amid growth - Investing.com Australia
Wealthcare Advisory Partners LLC Takes $252,000 Position in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health, Inc.'s (NASDAQ:GH) P/S Is Still On The Mark Following 43% Share Price Bounce - Simply Wall St
Guardant stock jumps 12% on Medicare coverage expansion - MSN
Guardant Health director Tariq Musa sells shares worth $4,359 - MSN
Raymond James maintains Outperform on Guardant Health, $39 target - MSN
Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone - MSN
Why This Top 4% Cancer-Tied Stock Just Hit A 13-Month High - Investor's Business Daily
Canaccord maintains Guardant Health stock Buy rating and $42 target - MSN
Guardant Health Gains Medicare Coverage For Colorectal Cancer Monitoring Test - Yahoo Finance
5.26%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):